Showing results (131-140 of 166) with videos related to

Sort By:
Pageof 17
European Heart Journal|September 23, 2022
Albuminuria as a marker of systemic congestion in patients with heart failureEva M Boorsma, Jozine M Ter Maaten, Kevin Damman, et al.
Heart (British Cardiac Society)|September 24, 2016
Blood urea nitrogen-to-creatinine ratio in the general population and in patients with acute heart failureYuya Matsue, Peter van der Meer, Kevin Damman, et al.
European Journal of Heart Failure|May 15, 2022
Whole blood transcriptomic profiling identifies molecular pathways related to cardiovascular mortality in heart failureMintu Nath, Simon P R Romaine, Andrea Koekemoer, et al.
European Journal of Heart Failure|May 16, 2019
The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF studyGeorge Markousis-Mavrogenis, Jasper Tromp, Wouter Ouwerkerk, et al.
European Journal of Heart Failure|June 26, 2020
Effects of combined renin-angiotensin-aldosterone system inhibitor and beta-blocker treatment on outcomes in heart failure with reduced ejection fraction: insights from BIOSTAT-CHF and ASIAN-HF registriesWouter Ouwerkerk, Tiew-Hwa K Teng, Jasper Tromp, et al.
European Journal of Heart Failure|February 20, 2018
CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients-who is doing what to whom and how?Kenneth Dickstein, Camilla Normand, Angelo Auricchio, et al.
European Journal of Heart Failure|January 13, 2018
Potassium and the use of renin-angiotensin-aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT-CHFJoost C Beusekamp, Jasper Tromp, Haye H van der Wal, et al.
Heart (British Cardiac Society)|April 1, 2021
Telomere length is independently associated with all-cause mortality in chronic heart failureSimon P R Romaine, Matthew Denniff, Veryan Codd, et al.
BMC Medicine|November 11, 2016
Renal function estimation and Cockroft-Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: The Heart 'OMics' in AGEing (HOMAGE) and the high-risk myocardial infarction database initiativesJoão Pedro Ferreira, Nicolas Girerd, Pierpaolo Pellicori, et al.
International Journal of Cardiology|January 8, 2018
Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failureJozine M Ter Maaten, Adriaan A Voors, Kevin Damman, et al.
Pageof 17